Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J.
Hou J, et al. Among authors: niu j.
Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075.
Hepatology. 2008.
PMID: 18080339
Clinical Trial.